a slight trendgold
Stimulation and activation of hCMEC/D3 by 100 ng/mL of TNFα for 6 h shows a slight trend towards an increase in CNR1 but it is not statistically significant.
Stimulation and activation of hCMEC/D3 by 100 ng/mL of TNFα for 6 h shows a slight trend towards an increase in CNR1 but it is not statistically significant.
When stratifying by AKI severity ( Fig S1 ), we observed only a slight trend toward decrease of stage 3.
Based on our analysis of the relationship between procedural deferral and local COVID-19 burden, we discovered a slight trend toward an association between the 2 during COVID II, but not COVID I.
A 2018 study revealed that 90% of the Chairs of ophthalmology are men but with a slight trend of recent female Chair appointments. 6 Historically, being a PD has been seen as a pathway to leadership within a medical department, whereas being a DMSE has not been seen as a steppingstone to further academic leadership within a department. 7 The purpose of this study is to analyze the data from the AUPO registry to specifically determine the similarities and differences in demographic trends for DMSEs and PDs from 2010 to 2019.
There is a noted shift in gender ratios from more females in initial records to a slight trend favoring males in the final records, a choice influenced by both breeders and owners.
While our 2D random section data suggested only a slight trend towards larger ribbons in type I VHCs ( Figure 1I ), the large volume data enabled more accurate quantification of individual ribbon volumes ( Figures 4E–G ; Supplementary Table S6 ) alongside the number of cluster-associated SVs.
The data show a slight trend toward decreased survival in the TBR:SSR sequential exposure compared to SSR:TBR sequential exposure but was not found to be significant.
reported the AT LISA toric 909 M IOL had a slight trend of overcorrection of refractive astigmatism 6 .
Also, with a slight trend for increased levels of PKA-Cα in depressed suicide victims only as compared to healthy controls.
We found only a slight trend towards a shortening of the snout in domesticates, which was not statistically significant based on a p -value cutoff of 0.05.
A slight trend of weakening association with time could potentially be discerned for birth order, with the pooled effect size on the edge of being significant – albeit with df = 2.13—for studies published before 2000 (RR 0.89, 95% CI 0.79–1) compared to later studies (RR 0.93, 95% CI 0.83–1.03).
In total CD4+ T-cells isolated from 5 healthy donors, we observed no significant toxicity at 72 or 96 h after treatment with EED226 (up to 20 μM), A-395 (up to 20 μM), or GSK-343 (up to 5 μM), while we observed a minor decrease in viability at 5 μM UNC1999 ( Figure 8 A and 8 B), consistent with toxicity at this dose of UNC1999 in Jurkat cells. We observed no major change in the expression of either CD69 or CD25 in treated cells at 72 ( Figure 8 C) or 96 h ( Figure 8 D), although a slight trend toward activation in 5 μM UNC1999 treated cells was observed which is consistent with the toxicity data.
In the present study, there was a slight trend towards higher PA in patients with higher BMI, which might indicate that at a higher BMI, the patients’ health allows them to be more physically active.
After these 27 knees, the process seemed to stabilize at the 180° target, with a slight trend towards varus knees.
Combinations of bevacizumab and erlotinib were also explored in the first-line setting demonstrating a significant increase in PFS but only a slight trend of OS improvement with the combination [ 71 – 73 ] (I,B).
A slight trend in decreased mental health and functioning problems (most subscales of BASIS-24 and the IFIP question on symptom burden), and in increased recovery and quality of life (ReQoL, MANSA) were experienced in both arms, from 0 to 12 months, but all differences were non-significant.
The observed effect was a slight trend toward a poorer PWR performance of the groups with the lowest Full Scale-IQ (i.e., IQ < 80) in comparison with other groups with higher IQ.
Only a slight trend of difference was found between memory SCI/normal groups in conversion rates from normal to abnormal.
Although a slight trend towards higher frequency of health-promoting behavior was observed for diabetes patients, this tendency disappeared after correction for multiple comparisons.
There was a slight trend towards a higher incidence of stent migration in the laser-cut group, although no significant difference was observed.
There was a slight trend towards reduced blood pressure during and immediately post-infusion that normalized by the end of the post-infusion follow-up.
Nevertheless, for de novo emergence of resistance, there was a slight trend observable which suggested a benefit of using a higher number of antibiotics.
The present study revealed a slight trend away from this practice as only 69% of surgeons were starting passive ROM within 2 weeks.
To account for a slight trend towards fewer lesions in SLC25A51 knockdown cells even directly following H 2 O 2 treatment, lesions after 2 and 4 h recovery were normalized to the first timepoint, H 2 O 2 treatment without recovery.
9 A slight trend of nonlinearity was observed at doses ≤1.0 mg/kg (Figure 3 ), possibly related to target‐mediated clearance at lower etrolizumab serum concentrations. 9 The slight nonlinearity of PK at doses ≤1.0 mg/kg resulted in shorter half‐lives at lower doses (4.8 to 7.4 days at 0.3 to 1 mg/kg) compared with longer half‐lives at higher doses (10.6 to 13.1 days at 3 to 10 mg/kg).